Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan

Fig. 1

Changes from baseline in skin sclerosis and pulmonary function over an 8-year period. Mean changes from baseline in the modified Rodnan skin score (mRSS; shown in a), percent predicted forced vital capacity (FVC; shown in b) and diffusing capacity of carbon monoxide (DLCO; shown in c) over an 8-year period. Results from the CD34-selected group and the unmanipulated group were compared. In the analysis of mRSS, patients with moderate-to-severe skin sclerosis (mRSS, ≥ 15) were included (CD34-selected, n = 9; unmanipulated, n = 6). Error bars represent standard deviation

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us